Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 February 2010

Associations of acute-phase reactants with metabolic syndrome in middle-aged overweight or obese people

Natalia G. VallianouAEF, Angelos A. EvangelopoulosAEF, Demosthenes B. PanagiotakosCD, Aikaterini T. GeorgiouB, Georgios A. ZachariasB, Evangelos D. VogiatzakisAB, Peter C. AvgerinosAD

Med Sci Monit 2010; 16(2): CR56-60 :: ID: 878351

Abstract

Background
Metabolic syndrome, i.e. the clustering of visceral obesity, dyslipidemia, hyperglycemia, and hypertension, has become a major public-health challenge worldwide. An acute-phase reactant is one whose level increases by 25% of the standard value during inflammation. Associations of acute-phase reactants with the components of metabolic syndrome among overweight or obese patients has rarely been examined.
Material and Method
The CRP, ferritin, fibrinogen, haptoglobin, and ESR levels of 117 consecutive overweight or obese patients were measured. Metabolic syndrome was defined if central obesity was combined with at least two of the following factors: triglyceride level > or = 150 mg/dl or specific treatment for this abnormality, HDL cholesterol < 40 mg/dl in males and < 50 mg/dl in females or specific treatment for this abnormality, systolic/diastolic blood pressures > or = 130/85 mmHg or treatment of previously diagnosed hypertension, and fasting plasma glucose > or = 100 mg/dl or previously diagnosed type 2 diabetes.
Results
Eighty-two patients were characterized as having metabolic syndrome and 35 as healthy controls. CRP, haptoglobin, and ESR levels increased with increasing number of components of metabolic syndrome. Ferritin and fibrinogen, in contrast, were increased in patients with metabolic syndrome but did not correlate with the number of components.
Conclusions
CRP, haptoglobin, and ESR may add significant information regarding the severity of metabolic syndrome among overweight and obese patients.

Keywords: Obesity - metabolism, Metabolic Syndrome X - metabolism, Biological Markers - metabolism, Acute-Phase Proteins - metabolism, Overweight - metabolism

Add Comment 0 Comments

Editorial

01 September 2024 : Editorial  

Editorial: Reasons for Increasing Global Concerns for the Spread of Mpox

Dinah V. Parums

DOI: 10.12659/MSM.946343

Med Sci Monit 2024; 30:e946343

0:00

In Press

Review article  

Pharmacological Strategies in Dermatomyositis: Current Treatments and Future Directions

Med Sci Monit In Press; DOI: 10.12659/MSM.944564  

Clinical Research  

Effect of Hyaluronic Acid on Socket Healing After Lower Impacted Third Molar Tooth Extraction in 40 Dental ...

Med Sci Monit In Press; DOI: 10.12659/MSM.945386  

Review article  

Cariprazine in Psychiatry: A Comprehensive Review of Efficacy, Safety, and Therapeutic Potential

Med Sci Monit In Press; DOI: 10.12659/MSM.945411  

Clinical Research  

Influenza Hemagglutinin Antibody Levels in the Elderly: Impact of Sex, Age, and Influenza/COVID-19 Vaccinat...

Med Sci Monit In Press; DOI: 10.12659/MSM.945002  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,049,426

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research   1,832,003

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   692,876

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

07 Jan 2022 : Meta-Analysis   257,339

Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...

DOI :10.12659/MSM.935074

Med Sci Monit 2022; 28:e935074

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750